204 related articles for article (PubMed ID: 35549776)
1. Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography videos.
Zhang L; Jiang Y; Jin Z; Jiang W; Zhang B; Wang C; Wu L; Chen L; Chen Q; Liu S; You J; Mo X; Liu J; Xiong Z; Huang T; Yang L; Wan X; Wen G; Han XG; Fan W; Zhang S
Cancer Imaging; 2022 May; 22(1):23. PubMed ID: 35549776
[TBL] [Abstract][Full Text] [Related]
2. Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound.
Liu D; Liu F; Xie X; Su L; Liu M; Xie X; Kuang M; Huang G; Wang Y; Zhou H; Wang K; Lin M; Tian J
Eur Radiol; 2020 Apr; 30(4):2365-2376. PubMed ID: 31900703
[TBL] [Abstract][Full Text] [Related]
3. Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging.
Peng J; Kang S; Ning Z; Deng H; Shen J; Xu Y; Zhang J; Zhao W; Li X; Gong W; Huang J; Liu L
Eur Radiol; 2020 Jan; 30(1):413-424. PubMed ID: 31332558
[TBL] [Abstract][Full Text] [Related]
4. Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma.
Sun Z; Shi Z; Xin Y; Zhao S; Jiang H; Li J; Li J; Jiang H
Acad Radiol; 2023 Sep; 30 Suppl 1():S81-S91. PubMed ID: 36803649
[TBL] [Abstract][Full Text] [Related]
5. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
6. Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC.
Müller L; Kloeckner R; Mähringer-Kunz A; Stoehr F; Düber C; Arnhold G; Gairing SJ; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Hahn F
Eur Radiol; 2022 Sep; 32(9):6302-6313. PubMed ID: 35394184
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
Nakano MM; Yamamoto A; Nishida N; Hamuro M; Hamamoto S; Jogo A; Sohgawa E; Kageyama K; Minami T; Miki Y
Jpn J Radiol; 2019 Jul; 37(7):543-548. PubMed ID: 31055710
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
[TBL] [Abstract][Full Text] [Related]
9. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma.
Liang L; Li C; Wang MD; Wang H; Zhou YH; Zeng YY; Zhang WG; Chen TH; Wang NY; Li J; Zhang YM; Wang Y; Gu WM; Xing H; Diao YK; Lau WY; Zhang CW; Pawlik TM; Shen F; Huang DS; Yang T
J Hematol Oncol; 2021 Oct; 14(1):165. PubMed ID: 34641921
[TBL] [Abstract][Full Text] [Related]
11. Optimized Performance of FlightPlan during Chemoembolization for Hepatocellular Carcinoma: Importance of the Proportion of Segmented Tumor Area.
Joo SM; Kim YP; Yum TJ; Eun NL; Lee D; Lee KH
Korean J Radiol; 2016; 17(5):771-8. PubMed ID: 27587967
[TBL] [Abstract][Full Text] [Related]
12. Dual-phase Cone-beam CT-based Navigation Imaging Significantly Enhances Tumor Detectability and Aids Superselective Transarterial Chemoembolization of Liver Cancer.
Yao X; Yan D; Jiang X; Li X; Zeng H; Liu D; Li H
Acad Radiol; 2018 Aug; 25(8):1031-1037. PubMed ID: 29398432
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Real-Time Fluoroscopy Analysis on Measurement of the Hepatic Arterial Flow During Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Comparison with Quantitative Digital Subtraction Angiography Analysis.
Lin YY; Lee RC; Guo WY; Chu WF; Wu FC; Gehrisch S
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1557-1563. PubMed ID: 27485268
[TBL] [Abstract][Full Text] [Related]
14. Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.
Liu QY; He CD; Zhou Y; Huang D; Lin H; Wang Z; Wang D; Wang JQ; Liao LP
World J Gastroenterol; 2016 Mar; 22(11):3242-51. PubMed ID: 27004002
[TBL] [Abstract][Full Text] [Related]
15. Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Park C; Kim JH; Kim PH; Kim SY; Gwon DI; Chu HH; Park M; Hur J; Kim JY; Kim DJ
Korean J Radiol; 2021 Feb; 22(2):213-224. PubMed ID: 32901464
[TBL] [Abstract][Full Text] [Related]
16. Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models.
Vosshenrich J; Zech CJ; Heye T; Boldanova T; Fucile G; Wieland S; Heim MH; Boll DT
Eur Radiol; 2021 Jun; 31(6):4367-4376. PubMed ID: 33274405
[TBL] [Abstract][Full Text] [Related]
17. Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography.
Iwazawa J; Ohue S; Mitani T; Abe H; Hashimoto N; Hamuro M; Nakamura K
AJR Am J Roentgenol; 2009 Apr; 192(4):1057-63. PubMed ID: 19304714
[TBL] [Abstract][Full Text] [Related]
18. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a predictive model for short-term efficacy of transcatheter arterial chemoembolization treatment in hepatocellular carcinoma and its clinical application.
Wei J; Wang Z
J Cancer Res Ther; 2019; 15(4):941-946. PubMed ID: 31436256
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
Ando Y; Kawaoka T; Amioka K; Naruto K; Ogawa Y; Yoshikawa Y; Kikukawa C; Kosaka Y; Uchikawa S; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Fukuhara T; Mori N; Takaki S; Tsuji K; Nonaka M; Hyogo H; Aisaka Y; Masaki K; Honda Y; Moriya T; Naeshiro N; Takahashi S; Imamura M; Chayama K; Aikata H
Oncology; 2021; 99(8):507-517. PubMed ID: 33946070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
